Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian…

§1Bibliographic record

§1.1Record

Authors

Mu Y, Bao X, Eliaschewitz FG, Hansen MR, Kim BT, Koroleva A, Ma RCW, Yang T, Zu N, Liu M

Title

Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

Source

The Lancet Diabetes & Endocrinology

Year

2024

Volume, issue, pages

12(3):184–195

Digital object identifier

not held by the Institute

PubMed identifier

not held by the Institute

Record type

Journal article

Institute identifier

CEI-BR-077

Institute note. The PubMed identifier previously carried on this record did not resolve and has been withdrawn. Journal and year are retained.

§1.2Institute documents citing this record

No Institute document currently cites this record. It is held in the bibliography because it was retrieved during a search and assessed, and the Institute records what it assessed and did not use as well as what it used.

§1.3Subject tags

semaglutide china STEP